Fintel reports that on October 21, 2024, Piper Sandler initiated coverage of Capricor Therapeutics (NasdaqCM:CAPR) with a ...

On Wednesday, Capricor Therapeutics Inc (CAPR) stock saw a modest uptick, ending the day at $21.39 which represents a slight increase of $1.25 or 6.21% from the prior close of $20.14. The stock opened ...

Deep-pocketed investors have adopted a bearish approach towards Capricor Therapeutics CAPR, and it's something market players ...

On Friday, Capricor Therapeutics Inc (CAPR) stock saw a modest uptick, ending the day at $18.86 which represents a slight increase of $0.37 or 2.00% from the prior close of $18.49. The stock opened at ...

Capricor Therapeutics shares are trading lower by 2.7% during Thursday's session. The company earlier commenced its public ...

Equities research analysts at Piper Sandler assumed coverage on shares of Capricor Therapeutics (NASDAQ:CAPR – Get Free Report) in a note issued to investors on Monday, Ratings reports. The firm set ...

Capricor (CAPR) stock rose 5% after the company reported long-term data from a study of its drug deramiocel in the treatment ...

Oppenheimer analyst Leland Gershell maintained a Buy rating on Capricor Therapeutics (CAPR – Research Report) today and set a price ...

Capricor Therapeutics (CAPR) closed the last trading session at $18.09, gaining 330.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets ...

Capricor Therapeutics Inc (NASDAQ:CAPR – Get Free Report) has received a consensus recommendation of “Buy” from the five ...

There are no important events for this country at this time. Select "All" to see top events in other countries or view all events.

We recently compiled a list of 7 Best Russell 2000 Stocks to Buy According to Analysts. In this article, we will look at ...